We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.49B
1-Year Est. Return
208.7%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
+208.7%
3 Year Est. Return
+777.5%
5 Year Est. Return
+1,114.43%
10 Year Est. Return
+23,630.52%
AUM
$568M
AUM Growth
–
Cap. Flow
+$533M
Cap. Flow
% of AUM
93.89%
Top 10 Holdings %
Top 10 Hldgs %
47.49%
Holding
49
New
48
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$36.3M |
| 2 |
Align Technology
ALGN
|
+$36.1M |
| 3 |
HCA Healthcare
HCA
|
+$28.4M |
| 4 |
Cardinal Health
CAH
|
+$26.7M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$25.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 81.21% |
| 2 | Miscellaneous | 14.96% |
| 3 | Communication Services | 1.99% |
| 4 | Consumer Staples | 1.28% |
| 5 | Industrials | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Align Technology
ALGN
$11.2B
| $38.8M | 6.84% |
+1,048,559
| New | +$36.1M |
|
|
ONXX
2
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $34.2M | 6.03% |
+393,981
| New | +$36.3M |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $31.8M | 5.61% |
+475,377
| New | +$21.4M |
|
|
4
Cardinal Health
CAH
$54.6B
| $27.6M | 4.86% |
+584,000
| New | +$26.7M |
|
|
5
HCA Healthcare
HCA
$90.5B
| $26.4M | 4.66% |
+733,300
| New | +$28.4M |
|
6
Puma Biotechnology
PBYI
$468M
| $24M | 4.22% |
+539,994
| New | +$19M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $23.5M | 4.14% |
+401,800
| New | +$24.2M |
|
|
ARIA
8
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $22.3M | 3.94% |
+1,277,109
| New | +$22.6M |
|
|
ARRY
9
DELISTED
Array Biopharma Inc
ARRY
| $21.7M | 3.82% |
+4,769,368
| New | +$25.7M |
|
|
IPXL
10
DELISTED
Impax Laboratories, Inc.
IPXL
| $19.2M | 3.38% |
+961,100
| New | +$17.1M |
|
|
NUVA
11
DELISTED
NuVasive, Inc.
NUVA
| $18.9M | 3.34% |
+763,992
| New | +$16.7M |
|
12
Insulet
PODD
$10.1B
| $18M | 3.17% |
+573,300
| New | +$16.2M |
|
|
HTWR
13
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $15.4M | 2.72% |
+162,325
| New | +$14.8M |
|
14
Tenet Healthcare
THC
$21.5B
| $14.6M | 2.57% |
+316,200
| New | +$14.2M |
|
15
Brookdale Senior Living
BKD
$2.8B
| $14.4M | 2.55% |
+546,500
| New | +$15.1M |
|
16
Regeneron Pharmaceuticals
REGN
$81.8B
| $13.7M | 2.42% |
+61,000
| New | +$14.2M |
|
17
Zimmer Biomet
ZBH
$19.2B
| $13.3M | 2.35% |
+183,237
| New | +$13.7M |
|
|
VHS
18
DELISTED
VANGUARD HEALTH SYS INC COM STK (DE)
VHS
| $13.3M | 2.35% |
+641,955
| New | +$9.07M |
|
19
Globus Medical
GMED
$11.1B
| $11.8M | 2.08% |
+700,700
| New | +$10.8M |
|
20
CALL
Merck
MRK
$366B
| $11.6M | 2.05% |
+262,000
| New | +$11.7M |
|
|
MODN
21
DELISTED
MODEL N, INC.
MODN
| $11.3M | 1.99% |
+484,600
| New | +$9.75M |
|
|
CPHD
22
DELISTED
Cepheid Inc
CPHD
| $11M | 1.93% |
+318,900
| New | +$11.7M |
|
|
CMRX
23
DELISTED
Chimerix, Inc.
CMRX
| $10.9M | 1.93% |
+450,800
| New | +$9.43M |
|
24
Cerus
CERS
$534M
| $10.7M | 1.89% |
+2,425,400
| New | +$11.7M |
|
|
AGN
25
DELISTED
Allergan Inc
AGN
| $10.7M | 1.89% |
+127,027
| New | +$13.2M |
|
Similar funds
FCM
MM
WA
ACB
LCS
GAM
MFWP
PMG
Redmile Group's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Redmile Group, which disclosed 49 positions worth $568M. Its ten largest holdings account for 47% of the portfolio.
Its largest position is ONYX PHARMACEUTICALS INC: 393,981 shares worth $34.2M.
By sector, the portfolio is most concentrated in Healthcare at 81% of assets, followed by Miscellaneous and Communication Services.
- Redmile Group's largest Q2 2013 buy was ONYX PHARMACEUTICALS INC: 393,981 shares worth $34.2M.
- Redmile Group's ten largest holdings make up 47% of its $568M portfolio in Q2 2013.
- Redmile Group disclosed 49 positions in Q2 2013, its first 13F filing on record.
Based on Redmile Group's 13F filing for Q2 2013, filed 14 Aug 2013.